Cargando…
Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types
The Cancer Genome Atlas (TCGA) has accrued RNA-Seq-based transcriptome data for more than 4000 cancer tissue samples across 12 cancer types, translating these data into biological insights remains a major challenge. We analyzed and compared the transcriptomes of 4043 cancer and 548 normal tissue sam...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544034/ https://www.ncbi.nlm.nih.gov/pubmed/26292924 http://dx.doi.org/10.1038/srep13413 |
_version_ | 1782386638251360256 |
---|---|
author | Peng, Li Bian, Xiu Wu Li, Di Kang Xu, Chuan Wang, Guang Ming Xia, Qing You Xiong, Qing |
author_facet | Peng, Li Bian, Xiu Wu Li, Di Kang Xu, Chuan Wang, Guang Ming Xia, Qing You Xiong, Qing |
author_sort | Peng, Li |
collection | PubMed |
description | The Cancer Genome Atlas (TCGA) has accrued RNA-Seq-based transcriptome data for more than 4000 cancer tissue samples across 12 cancer types, translating these data into biological insights remains a major challenge. We analyzed and compared the transcriptomes of 4043 cancer and 548 normal tissue samples from 21 TCGA cancer types, and created a comprehensive catalog of gene expression alterations for each cancer type. By clustering genes into co-regulated gene sets, we identified seven cross-cancer gene signatures altered across a diverse panel of primary human cancer samples. A 14-gene signature extracted from these seven cross-cancer gene signatures precisely differentiated between cancerous and normal samples, the predictive accuracy of leave-one-out cross-validation (LOOCV) were 92.04%, 96.23%, 91.76%, 90.05%, 88.17%, 94.29%, and 99.10% for BLCA, BRCA, COAD, HNSC, LIHC, LUAD, and LUSC, respectively. A lung cancer-specific gene signature, containing SFTPA1 and SFTPA2 genes, accurately distinguished lung cancer from other cancer samples, the predictive accuracy of LOOCV for TCGA and GSE5364 data were 95.68% and 100%, respectively. These gene signatures provide rich insights into the transcriptional programs that trigger tumorigenesis and metastasis, and many genes in the signature gene panels may be of significant value to the diagnosis and treatment of cancer. |
format | Online Article Text |
id | pubmed-4544034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-45440342015-09-01 Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types Peng, Li Bian, Xiu Wu Li, Di Kang Xu, Chuan Wang, Guang Ming Xia, Qing You Xiong, Qing Sci Rep Article The Cancer Genome Atlas (TCGA) has accrued RNA-Seq-based transcriptome data for more than 4000 cancer tissue samples across 12 cancer types, translating these data into biological insights remains a major challenge. We analyzed and compared the transcriptomes of 4043 cancer and 548 normal tissue samples from 21 TCGA cancer types, and created a comprehensive catalog of gene expression alterations for each cancer type. By clustering genes into co-regulated gene sets, we identified seven cross-cancer gene signatures altered across a diverse panel of primary human cancer samples. A 14-gene signature extracted from these seven cross-cancer gene signatures precisely differentiated between cancerous and normal samples, the predictive accuracy of leave-one-out cross-validation (LOOCV) were 92.04%, 96.23%, 91.76%, 90.05%, 88.17%, 94.29%, and 99.10% for BLCA, BRCA, COAD, HNSC, LIHC, LUAD, and LUSC, respectively. A lung cancer-specific gene signature, containing SFTPA1 and SFTPA2 genes, accurately distinguished lung cancer from other cancer samples, the predictive accuracy of LOOCV for TCGA and GSE5364 data were 95.68% and 100%, respectively. These gene signatures provide rich insights into the transcriptional programs that trigger tumorigenesis and metastasis, and many genes in the signature gene panels may be of significant value to the diagnosis and treatment of cancer. Nature Publishing Group 2015-08-21 /pmc/articles/PMC4544034/ /pubmed/26292924 http://dx.doi.org/10.1038/srep13413 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Peng, Li Bian, Xiu Wu Li, Di Kang Xu, Chuan Wang, Guang Ming Xia, Qing You Xiong, Qing Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title | Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title_full | Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title_fullStr | Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title_full_unstemmed | Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title_short | Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types |
title_sort | large-scale rna-seq transcriptome analysis of 4043 cancers and 548 normal tissue controls across 12 tcga cancer types |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544034/ https://www.ncbi.nlm.nih.gov/pubmed/26292924 http://dx.doi.org/10.1038/srep13413 |
work_keys_str_mv | AT pengli largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT bianxiuwu largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT lidikang largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT xuchuan largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT wangguangming largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT xiaqingyou largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes AT xiongqing largescalernaseqtranscriptomeanalysisof4043cancersand548normaltissuecontrolsacross12tcgacancertypes |